Holen Sie sich die Stockscreener-App
0.526
2.59%
-0.014
Handel nachbörslich:
.54
0.014
+2.66%
Nexgel Inc Aktie (NXGL) Neueste Nachrichten
NexGel Inc stock (US65340W1027): hydrogel specialist with micro-cap profile on Nasdaq - AD HOC NEWS
Langhorne’s Nexgel transforms near disaster into ‘three-team trade’ acquisition - MSN
NXGL Should I Buy - Intellectia AI
NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan
NXGL Stock Price, Quote & Chart | NEXGEL INC (NASDAQ:NXGL) - ChartMill
Maxim Group Maintains NexGel(NXGL.US) With Buy Rating, Maintains Target Price $2 - Moomoo
NexGel Inc stock (US65340W1027): clinical laser study puts hydrogel specialist in focus - AD HOC NEWS
Nexgel hydrogel patch reduces laser plume in hair removal study By Investing.com - Investing.com South Africa
Nexgel hydrogel patch reduces laser plume in hair removal study - Investing.com
New laser hair removal patch cuts carcinogenic plume, eases pain in study - Stock Titan
Director boosts NEXGEL (NXGL) exposure with convertible note and warrant - Stock Titan
NEXGEL (NXGL) director buys $1M convertible note and stock warrant - Stock Titan
NEXGEL (NXGL) CEO acquires convertible note and 50,000-share stock warrant - Stock Titan
NEXGEL (NXGL) director Harris Kevin McClain listed on Form 3 - Stock Titan
NEXGEL (NASDAQ: NXGL) director lists warrant and note positions - Stock Titan
NexGel Inc stock (US65340W1027): Q1 2026 numbers put hydrogel growth story in focus - AD HOC NEWS
NEXGEL, Inc. (NASDAQ:NXGL) Q1 2026 Earnings Call Transcript - Insider Monkey
Nexgel Earnings Call: BioNX Bet Amid Cash Strain - TipRanks
NexGel Raises Insider-Funded Convertible Notes to Bolster Liquidity - TipRanks
NEXGEL Adds Sequence Executives to Board After Deal Financing - MyChesCo
NexGel Raises $1.21 Million Via Convertible Notes and Warrants; $0.60 Conversion, $0.80 Exercise - TradingView
NexGel (NASDAQ: NXGL) sells $1.21M in convertible notes with warrants - Stock Titan
Nexgel (NXGL) Q1 2026 Earnings Transcript - The Globe and Mail
NXGL: BioNX acquisition set to triple annual revenue and drive immediate profitability - TradingView
Earnings call transcript: Nexgel Q1 2026 reveals revenue decline, stock dips - Investing.com India
NXGL: BioNX acquisition set to triple revenue and drive profitability as legacy business stabilizes - TradingView
NexGel Q1 2026 Earnings Call Transcript - Benzinga
Nexgel Inc reports results for the quarter ended March 31Earnings Summary - TradingView
NXGL: Q1 2026 saw revenue down 5.6%, a $927K net loss, and a major acquisition funded by new capital - TradingView
NEXGEL, INC. 1Q 2026: Revenue $2.65M, EPS $(0.11) — 10-Q Summary - TradingView
NexGel (NASDAQ: NXGL) posts Q1 2026 loss and flags going concern risks amid new debt - Stock Titan
NEXGEL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
NexGel Inc (NXGLW) Stock: Consolidating at $$0.05 — Next Move Ahead 2026-05-14Sector Leader - newser.com
Nexgel appoints Dave Hazard as VP of sales for BIONX Surgical By Investing.com - Investing.com India
NEXGEL, Inc. announced that it has received $1.21 million in funding - marketscreener.com
TradingKey - TradingKey
Nexgel appoints Dave Hazard as VP of sales for BIONX Surgical - Investing.com Australia
Nexgel appoints Dave Hazard as vice president of sales for Bionx Surgical - marketscreener.com
NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical - GlobeNewswire
Nexgel Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
NEXGEL Strengthens Board with Sequence LifeScience Leaders - TipRanks
Sequence execs join NEXGEL (NASDAQ: NXGL) board after $5.5M note deal - Stock Titan
Earnings Preview: NexGel to Report Financial Results Pre-market on May 15 - 富途牛牛
NEXGEL To Report First Quarter 2026 Financial Results on May 15th - The Manila Times
NEXGEL, Inc. to Announce First Quarter 2026 Financial Results on May 15, 2026, with Conference Call Scheduled for 12:00 P.M. ET - Quiver Quantitative
NEXGEL, Inc. announced that it expects to receive $1.21 million in funding - marketscreener.com
NEXGEL, Inc. announced that it has received $1 million in funding - marketscreener.com
NexGel (NXGL) Eps Diluted (TTM) - Zacks Investment Research
NXGLW NexGel Inc warrant holders await quarterly earnings details as report data remains unavailable, stock movement muted today.Credit Risk - newser.com
NEXGEL (NXGL) CFO details warrants, convertible note and 160,000-share option - Stock Titan
Sequence LifeScience, Inc. announced that it has received $5.5 million in funding from NEXGEL, Inc. - marketscreener.com
After $5.5M deal backing, Sequence executives take 2 NEXGEL board seats - Stock Titan
NEXGEL Appoints Brian Kieser and Kevin Harris from New - GlobeNewswire
NEXGEL Appoints Ian Blackman CFO Amid Celularity Deal - MyChesCo
1.04%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):